This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Sanofi (SNY)

NYSE: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 45.99B 47.55B 45.44B 42.61B
Cost of Sales 11.51B 12.57B 11.23B 10.04B
Gross Operating Profit 34.48B 34.99B 34.21B 32.56B
Selling, General, and Administrative Expenses 12.21B 12.43B 11.47B 10.43B
Research & Development 6.59B 6.51B 6.24B 5.85B
Operating Income before D & A (EBITDA) 15.68B 16.04B 16.50B 16.28B
Depreciation & Amortization 7.69B 6.49B 7.20B 6.82B
Interest Income 150.52M 122.99M 181.45M 139.65M
Other Income - Net 1.00B 1.26B 1.40B 1.59B
Special Income / Charges -1.48B -408.65M -184.05M 0.00
Total Income Before Interest Expenses (EBIT) 7.25B 9.02B 9.00B 9.37B
Interest Expense 845.09M 731.35M 715.44M 621.09M
Pre-Tax Income 6.40B 8.29B 8.28B 8.75B
Income Taxes 1.05B 1.50B 589.72M 1.65B
Minority Interest 218.18M 223.50M 312.36M 337.81M
Net Income From Continuing Operations 5.35B 6.79B 7.69B 7.10B
Net Income From Discontinued Operations 0.00 0.00 0.00 513.37M
Net Income From Total Operations 5.35B 6.79B 7.69B 7.61B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 5.13B 6.57B 7.38B 7.27B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
7.25B 8.71B 9.58B 8.92B
Preferred Dividends
Net Income Available To Common 5.35B 6.79B 7.69B 7.10B
Basic EPS from Continuing Ops. 1.94 2.49 2.79 2.59
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.20
Basic EPS from Total Operations 1.94 2.49 2.79 2.79
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.94 2.49 2.79 2.79
Basic Normalized Net Income/Share 2.63 3.19 3.48 3.25
EPS fr Continuing Ops. 1.92 2.47 2.78 2.58
EPS fr Discontinued Ops 0.00 0.00 0.00 0.20
EPS fr Total Ops. 1.92 2.47 2.78 2.78
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.92 2.47 2.78 2.78
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.60 3.17 3.46 3.25
Dividends Paid per Share 1.30 1.69 1.32 1.10
SNY News

Analysts Ratings for SNY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 3 3 3
Moderate Buy 0 0 0 0
Hold 4 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SNY ANALYST REPORT

Brokerage Partners

SNY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs